A detailed history of Covestor LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Covestor LTD holds 289 shares of UTHR stock, worth $105,291. This represents 0.06% of its overall portfolio holdings.

Number of Shares
289
Previous 465 37.85%
Holding current value
$105,291
Previous $148,000 30.41%
% of portfolio
0.06%
Previous 0.1%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$311.04 - $363.55 $54,743 - $63,984
-176 Reduced 37.85%
289 $103,000
Q2 2024

Aug 09, 2024

SELL
$228.26 - $319.04 $10,043 - $14,037
-44 Reduced 8.64%
465 $148,000
Q1 2024

May 10, 2024

BUY
$210.76 - $249.51 $48,685 - $57,636
231 Added 83.09%
509 $117,000
Q4 2023

Feb 09, 2024

SELL
$214.88 - $256.94 $114,745 - $137,205
-534 Reduced 65.76%
278 $61,000
Q3 2023

Nov 13, 2023

SELL
$211.82 - $248.24 $76,678 - $89,862
-362 Reduced 30.83%
812 $183,000
Q2 2023

Aug 11, 2023

BUY
$205.19 - $232.99 $54,785 - $62,208
267 Added 29.44%
1,174 $259,000
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $3,194 - $4,142
15 Added 1.68%
907 $203,000
Q4 2022

Feb 13, 2023

SELL
$205.95 - $280.43 $3,501 - $4,767
-17 Reduced 1.87%
892 $248,000
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $1,626 - $1,953
-8 Reduced 0.87%
909 $190,000
Q2 2022

Aug 10, 2022

BUY
$174.81 - $241.14 $6,992 - $9,645
40 Added 4.56%
917 $216,000
Q1 2022

May 13, 2022

BUY
$166.16 - $213.96 $95,043 - $122,385
572 Added 187.54%
877 $157,000
Q4 2021

Feb 10, 2022

BUY
$184.32 - $216.08 $56,217 - $65,904
305 New
305 $66,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.